BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
XOMA (NQ: XOMA)
4.320 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 16, 2014  /  Add to My Watchlist      
(XOMA) Community Analysis from
April 17, 2014
(Stock Blog Hub, 1/15/13)
XOMA Corporation (XOMA) recently announced interim data from a phase II proof-of-concept (POC) study on gevokizumab, which is being developed for the treatment of inflammatory facial lesions...(read more)
Courtesy of Benzinga. XOMA Corporation (Nasdaq: XOMA) today announced it has acquired U.S. rights to the perindopril franchise from...(read more)
(Phil’s Stock World, 12/30/11)
Courtesy of Benzinga. XOMA Ltd. (Nasdaq: XOMA) today announced that, effective December 31, 2011, it will move its corporate domicile from Bermuda to Delaware and change its name from "XOMA Ltd." to "XOMA Corporation." All of the outstanding common shares of the [...]
XOMA (XOMA) Company Overview

There is no analysis for XOMA yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here